Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALVAC-HIV and AIDSVAX B/E Prime-Boost HIV Vaccine Trial in Thai Adults
NCT00223080Phase 3Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Oct 2003
- Primary completion
- Jul 2006
- Modality
- Prophylactic Vaccines, Viral Vectors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of ALVAC-HIV, AIDSVAX B/E in human immunodeficiency virus infection (HIV), sponsored by U.S. Army Medical Research and Development Command. Started Oct 2003; status: completed.
02
Drugs
ALVAC-HIVAIDSVAX B/E
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00223080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00223080.